{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:05:15Z","timestamp":1771257915345,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1124\/dmd.121.000534","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T20:25:12Z","timestamp":1629404712000},"page":"972-984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of Food-Derived Isoflavone Sulfates as Inhibition Markers for Intestinal Breast Cancer Resistance Proteins"],"prefix":"10.1016","volume":"49","author":[{"given":"Rina","family":"Agustina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Masuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuto","family":"Kido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyosuke","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Ishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.121.000534_bib1","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1124\/dmd.111.040881","article-title":"Bioavailability of the glucuronide and sulfate conjugates of genistein and daidzein in breast cancer resistance protein 1 knockout mice","volume":"39","author":"\u00c1lvarez","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000534_bib2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/bdd.772","article-title":"The sulfated conjugate of biochanin A is a substrate of breast cancer resistant protein (ABCG2)","volume":"32","author":"An","year":"2011","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.121.000534_bib4","doi-asserted-by":"crossref","unstructured":"Chong J, Wishart DS, Xia J (2019) Using MetaboAnalyst 4.0 for comprehensive and integrative metabolomics data analysis. Curr Protoc Bioinforma 68.","DOI":"10.1002\/cpbi.86"},{"key":"10.1124\/dmd.121.000534_bib3","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1158\/1078-0432.CCR-07-4417","article-title":"A phase I and pharmacokinetic study of lapatinib in combination with letrozole in patients with advanced cancer","volume":"14","author":"Chu","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.121.000534_bib5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/cpt.1216","article-title":"Clinical probes and endogenous biomarkers as substrates for transporter drug-drug interaction evaluation: perspectives from the International Transporter Consortium","volume":"104","author":"Chu","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.121.000534_bib6","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1124\/mol.107.034751","article-title":"Effect of breast cancer resistance protein (Bcrp\/Abcg2) on the disposition of phytoestrogens","volume":"72","author":"Enokizono","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.121.000534_bib7","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1124\/dmd.106.011239","article-title":"Regional expression and activity of breast cancer resistance protein (Bcrp\/Abcg2) in mouse intestine: overlapping distribution with sulfotransferases","volume":"35","author":"Enokizono","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000534_bib8","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/bcp.12654","article-title":"Sulfasalazine disposition in a subject with 376C>T (nonsense mutation) and 421C>A variants in the ABCG2 gene","volume":"80","author":"Gotanda","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.121.000534_bib9","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1111\/bcp.13753","article-title":"Effect of multiple-dose osimertinib on the pharmacokinetics of simvastatin and rosuvastatin","volume":"84","author":"Harvey","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.121.000534_bib10","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1124\/dmd.111.038281","article-title":"Metabolism and disposition of isoflavone conjugated metabolites in humans after ingestion of kinako","volume":"39","author":"Hosoda","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000534_bib11","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nat Commun"},{"key":"10.1124\/dmd.121.000534_bib12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.omtm.2021.01.005","article-title":"Vinblastine treatment decreases the undifferentiated cell contamination of human iPSC-derived intestinal epithelial-like cells","volume":"20","author":"Ichikawa","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1124\/dmd.121.000534_bib13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1124\/dmd.114.062604","article-title":"Generation of enterocyte-like cells with pharmacokinetic functions from human induced pluripotent stem cells using small-molecule compounds","volume":"43","author":"Iwao","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000534_bib14","doi-asserted-by":"crossref","first-page":"15649","DOI":"10.1073\/pnas.202607599","article-title":"The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria","volume":"99","author":"Jonker","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.121.000534_bib15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.dmpk.2020.04.334","article-title":"Pharmacokinetic functions of human induced pluripotent stem cell-derived small intestinal epithelial cells","volume":"35","author":"Kabeya","year":"2020","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.121.000534_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/clpt.2009.79","article-title":"ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin","volume":"86","author":"Keskitalo","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.121.000534_bib17","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1124\/dmd.115.063867","article-title":"Gut microbiota-mediated drug-antibiotic interactions","volume":"43","author":"Kim","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000534_bib18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1124\/dmd.111.043067","article-title":"Species differences in tissue distribution and enzyme activities of arylacetamide deacetylase in human, rat, and mouse","volume":"40","author":"Kobayashi","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000534_bib19","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1124\/dmd.116.069336","article-title":"Characteristic analysis of intestinal transport in enterocyte-like cells differentiated from human induced pluripotent stem cells","volume":"44","author":"Kodama","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000534_bib20","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/jms.635","article-title":"Profiling of sulfoconjugates in urine by using precursor ion and neutral loss scans in tandem mass spectrometry. Application to the investigation of heavy metal toxicity in rats","volume":"39","author":"Lafaye","year":"2004","journal-title":"J Mass Spectrom"},{"key":"10.1124\/dmd.121.000534_bib21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.116.234914","article-title":"Coproporphyrins in plasma and urine can be appropriate clinical biomarkers to recapitulate drug-drug interactions mediated by organic anion transporting polypeptide inhibition","volume":"358","author":"Lai","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.121.000534_bib22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1124\/dmd.114.062174","article-title":"Breast cancer resistance protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug-drug interaction study design","volume":"43","author":"Lee","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000534_bib23","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/cts.12809","article-title":"Febuxostat, but not allopurinol, markedly raises the plasma concentrations of the breast cancer resistance protein substrate rosuvastatin","volume":"13","author":"Lehtisalo","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1124\/dmd.121.000534_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","article-title":"Role of the breast cancer resistance protein (BCRP\/ABCG2) in drug transport--an update","volume":"17","author":"Mao","year":"2015","journal-title":"AAPS J"},{"key":"10.1124\/dmd.121.000534_bib25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fphar.2016.00518","article-title":"Identification of febuxostat as a new strong ABCG2 inhibitor: potential applications and risks in clinical situations","volume":"7","author":"Miyata","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1124\/dmd.121.000534_bib26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2133\/dmpk.DMPK-12-RG-026","article-title":"Impact of genetic variation in breast cancer resistance protein (BCRP\/ABCG2) on sunitinib pharmacokinetics","volume":"27","author":"Mizuno","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.121.000534_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/dmd.120.000236","article-title":"Detoxication versus bioactivation pathways of lapatinib in vitro: UGT1A1 catalyzes the hepatic glucuronidation of debenzylated lapatinib","volume":"49","author":"Nardone-White","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000534_bib28","doi-asserted-by":"crossref","first-page":"e00478","DOI":"10.1002\/prp2.478","article-title":"Identification of equol-7-glucuronide-4\u2032-sulfate, monoglucuronides and monosulfates in human plasma of 2 equol producers after administration of kinako by LC-ESI-MS","volume":"7","author":"Obara","year":"2019","journal-title":"Pharmacol Res Perspect"},{"key":"10.1124\/dmd.121.000534_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/978-1-4939-7454-2_19","article-title":"Reconstitution and transport analysis of eukaryotic transporters in the post-genomic era","volume":"1700","author":"Omote","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1124\/dmd.121.000534_bib30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/dmd.107.018374","article-title":"The role of efflux and uptake transporters in [N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, lapatinib) disposition and drug interactions","volume":"36","author":"Polli","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000534_bib31","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/ajcn\/76.3.588","article-title":"Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage","volume":"76","author":"Shelnutt","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1124\/dmd.121.000534_bib32","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00204-016-1663-5","article-title":"Phase II metabolism of the soy isoflavones genistein and daidzein in humans, rats and mice: a cross-species and sex comparison","volume":"90","author":"Soukup","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.121.000534_bib33","doi-asserted-by":"crossref","first-page":"11310","DOI":"10.1021\/acs.analchem.0c01980","article-title":"Correlation-based deconvolution (CorrDec) to generate high-quality MS2 spectra from data-independent acquisition in multisample studies","volume":"92","author":"Tada","year":"2020","journal-title":"Anal Chem"},{"key":"10.1124\/dmd.121.000534_bib34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41592-019-0358-2","article-title":"A cheminformatics approach to characterize metabolomes in stable-isotope-labeled organisms","volume":"16","author":"Tsugawa","year":"2019","journal-title":"Nat Methods"},{"key":"10.1124\/dmd.121.000534_bib35","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1124\/dmd.116.071472","article-title":"Investigation of endogenous compounds applicable to drug-drug interaction studies involving the renal organic anion transporters, OAT1 and OAT3, in humans","volume":"44","author":"Tsuruya","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000534_bib36","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1096\/fj.12-210039","article-title":"ABCG2 functions as a general phytoestrogen sulfate transporter in vivo","volume":"26","author":"van de Wetering","year":"2012","journal-title":"FASEB J"},{"key":"10.1124\/dmd.121.000534_bib37","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1128\/MCB.01621-06","article-title":"Multidrug transporter ABCG2\/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk","volume":"27","author":"van Herwaarden","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1124\/dmd.121.000534_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.addr.2008.08.007","article-title":"Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice","volume":"61","author":"Vlaming","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.121.000534_bib40","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1124\/dmd.111.043901","article-title":"Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein","volume":"40","author":"Yang","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000534_bib41","doi-asserted-by":"crossref","unstructured":"Yasuda K, Ganguly S, Schuetz EG (2018) Pheophorbide A: fluorescent Bcrp substrate to measure oral drug-drug interactions in real time in vivo. Drug Metab Dispos 46:dmd.118.083584.","DOI":"10.1124\/dmd.118.083584"},{"key":"10.1124\/dmd.121.000534_bib42","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1124\/dmd.113.051409","article-title":"Minor compensatory changes in SAGE Mdr1a (P-gp), Bcrp, and Mrp2 knockout rats do not detract from their utility in the study of transporter-mediated pharmacokinetics","volume":"41","author":"Zamek-Gliszczynski","year":"2013","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624080395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624080395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.121.000534","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T12:52:36Z","timestamp":1740055956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624080395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0090955624080395"],"URL":"https:\/\/doi.org\/10.1124\/dmd.121.000534","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Food-Derived Isoflavone Sulfates as Inhibition Markers for Intestinal Breast Cancer Resistance Proteins","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.121.000534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}